NuGene International Inc
OTC:NUGN
NuGene International Inc
OTC:NUGN
Price:
1.16
USD
57 900%
Market Closed
Market Cap:
$64.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
NuGene International Inc
OTC:NUGN
|
US |
|
Metalart Corp
TSE:5644
|
JP |
|
Jagran Prakashan Ltd
NSE:JAGRAN
|
IN |
|
Prologue SA
PAR:ALPRG
|
FR |
|
S
|
Sif Holding NV
AEX:SIFG
|
NL |
|
K
|
KGHM Polska Miedz SA
OTC:KGHPF
|
PL |
|
Y
|
Yarrl SA
WSE:YRL
|
PL |
|
C
|
Celestica Inc
NYSE:CLS
|
CA |
|
S
|
Sta Lucia Land Inc
XPHS:SLI
|
PH |
|
D
|
Delfingen Industry SA
XBER:HBS
|
FR |
|
H
|
Hon Hai Precision Industry Co Ltd
LSE:HHPD
|
TW |
|
ISC Business Technology AG
F:I5Q1
|
CH |
|
Itausa SA
BOVESPA:ITSA4
|
BR |
|
S
|
Sun Life Financial Inc
NYSE:SLF
|
CA |
|
V
|
Vonovia SE
OTC:VNNVF
|
DE |
|
Baozun Inc
NASDAQ:BZUN
|
CN |
|
Alpen Co Ltd
TSE:3028
|
JP |
|
Asra Minerals Ltd
ASX:ASR
|
AU |
|
Diaceutics PLC
LSE:DXRX
|
UK |
|
H
|
Hefei Chipmore Technology Co Ltd
SSE:688352
|
CN |
|
S
|
SKF India Ltd
BSE:500472
|
IN |
|
V
|
Vrain Solution Inc
TSE:135A
|
JP |
|
Intergis Co Ltd
KRX:129260
|
KR |
|
EpiCentre Holdings Ltd
SGX:5MQ
|
SG |
Cash Flow Statement
Cash Flow Statement
NuGene International Inc
NuGene International Inc
Currency: USD
| Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Dec-2023 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||
| Net Income |
(0)
|
(1)
|
(1)
|
(3)
|
(5)
|
(6)
|
(7)
|
(11)
|
(12)
|
(7)
|
(6)
|
(6)
|
(1)
|
(1)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
1
|
0
|
|
| Other Non-Cash Items |
0
|
0
|
1
|
2
|
3
|
4
|
4
|
8
|
8
|
4
|
5
|
5
|
1
|
1
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
1
|
1
|
1
|
2
|
0
|
(0)
|
(0)
|
(2)
|
(2)
|
|
| Cash from Operating Activities |
(0)
N/A
|
(1)
-267%
|
(1)
-36%
|
(2)
-48%
|
(2)
-27%
|
(2)
+24%
|
(2)
+4%
|
(2)
-2%
|
(2)
-10%
|
(0)
+79%
|
(0)
+70%
|
0
N/A
|
(0)
N/A
|
(0)
-6%
|
|
| Investing Cash Flow | |||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(0)
|
(1)
|
|
| Other Items |
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-126%
|
(0)
-50%
|
(0)
-10%
|
(0)
+19%
|
(0)
+40%
|
(0)
+63%
|
(0)
+41%
|
(0)
+82%
|
(1)
-31 233%
|
(0)
+96%
|
(0)
-840%
|
(0)
+26%
|
(1)
-66%
|
|
| Financing Cash Flow | |||||||||||||||
| Net Issuance of Common Stock |
2
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
0
|
1
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Paid for Dividends |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
2
N/A
|
2
+3%
|
2
+17%
|
2
+25%
|
1
-48%
|
1
+15%
|
1
-10%
|
2
+34%
|
2
+12%
|
2
-9%
|
2
+9%
|
2
+6%
|
0
-78%
|
1
+54%
|
|
| Change in Cash | |||||||||||||||
| Net Change in Cash |
1
N/A
|
1
-54%
|
0
-20%
|
0
-29%
|
(1)
N/A
|
(0)
+64%
|
(0)
-1%
|
(0)
+90%
|
0
N/A
|
0
-54%
|
2
+18 200%
|
2
-1%
|
(0)
N/A
|
(0)
+67%
|
|
| Free Cash Flow | |||||||||||||||
| Free Cash Flow |
(0)
N/A
|
(1)
-240%
|
(1)
-37%
|
(2)
-43%
|
(3)
-23%
|
(2)
+25%
|
(2)
+7%
|
(2)
-1%
|
(2)
-8%
|
(2)
+8%
|
(2)
+14%
|
(2)
-9%
|
(1)
+71%
|
(1)
-45%
|
|
Switch to:
Switch to:
See Also
Discover More
